loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Ibafloxacin, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Ibafloxacin

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: Ibafloxacine, 91618-36-9, Ibaflin, R-835, S-25930, R835
    Molecular Formula
    C15H14FNO3
    Molecular Weight
    275.27  g/mol
    InChI Key
    DXKRGNXUIRKXNR-UHFFFAOYSA-N
    FDA UNII
    53VPK9R0T5
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
    2.1.2 InChI
    InChI=1S/C15H14FNO3/c1-7-3-4-9-8(2)12(16)5-10-13(9)17(7)6-11(14(10)18)15(19)20/h5-7H,3-4H2,1-2H3,(H,19,20)
    2.1.3 InChI Key
    DXKRGNXUIRKXNR-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1CCC2=C3N1C=C(C(=O)C3=CC(=C2C)F)C(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    53VPK9R0T5
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo(i,j)quinolizine-2-carboxylic Acid

    2. S 25930

    3. S-25930

    2.3.2 Depositor-Supplied Synonyms

    1. Ibafloxacine

    2. 91618-36-9

    3. Ibaflin

    4. R-835

    5. S-25930

    6. R835

    7. 53vpk9r0t5

    8. R 835

    9. R835;s25930

    10. S25930

    11. 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic Acid

    12. S 25930

    13. Ibafloxacino

    14. Ibafloxacinum

    15. 1h,5h-benzo(ij)quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-

    16. Ibafloxacine [inn-french]

    17. Ibafloxacinum [inn-latin]

    18. Ibafloxacino [inn-spanish]

    19. Unii-53vpk9r0t5

    20. Ibafloxacin [usan:inn:ban]

    21. 1h,5h-benzo[ij]quinolizine-2-carboxylic Acid, 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-

    22. Ibafloxacin [mi]

    23. Ibafloxacin [inn]

    24. Ibafloxacin (usan/inn)

    25. Ibafloxacin [usan]

    26. Dsstox_cid_31642

    27. Dsstox_rid_97526

    28. Ibafloxacin [mart.]

    29. Dsstox_gsid_57853

    30. Schembl154637

    31. Chembl170052

    32. Dtxsid8057853

    33. Gtpl10819

    34. Tox21_113686

    35. Hy-u00214

    36. Cs-7344

    37. Fluoro-dimethyl-oxo-[?]carboxylic Acid

    38. 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

    39. Ibafloxacin [ema Epar Veterinary]

    40. Ncgc00249910-01

    41. Cas-91618-36-9

    42. D04485

    43. Q5983609

    44. 6,7-dihydro-5,8-dimethyl-9- Fluoro-1-oxo-1h,5h-benzo[ij]quinolizine-2-carboxylic Acid

    45. 7-fluoro-8,12-dimethyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic Acid

    2.4 Create Date
    2005-08-01
    3 Chemical and Physical Properties
    Molecular Weight 275.27 g/mol
    Molecular Formula C15H14FNO3
    XLogP33.3
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count5
    Rotatable Bond Count1
    Exact Mass275.09577147 g/mol
    Monoisotopic Mass275.09577147 g/mol
    Topological Polar Surface Area57.6 Ų
    Heavy Atom Count20
    Formal Charge0
    Complexity490
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count1
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    * Dogs: :

    Ibaflin is indicated for the treatment of the following conditions in dogs:

    - dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible strains of Staphylococci, Escherichia coli and Proteus mirabilis;

    - acute, uncomplicated urinary-tract infections, caused by susceptible strains of Staphylococci, Proteus species, Enterobacter spp. , E. coli and Klebsiella spp. ;

    - respiratory-tract infections (upper tract) caused by susceptible strains of Staphylococci, E. coli, and Klebsiella spp.

    Ibaflin gel is indicated in dogs for the treatment of the following conditions:

    - dermal infections (pyoderma - superficial and deep, wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli and P. mirabilis.

    * Cats: :

    Ibaflin gel is indicated in cats for treatment of the following conditions:

    - dermal infections (soft-tissue infections - wounds, abscesses) caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Proteus spp. and Pasteurella spp. ;

    - upper respiratory-tract infections caused by susceptible pathogens such as Staphylococcus spp. , E. coli, Klebsiella spp. and Pasteurella spp.

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    QJ01MA96

    Post Enquiry
    POST ENQUIRY